Drug archive
Levodopa (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antidyskinetic
Description
Levodopa is used alone or in combination with carbidopa to treat Parkinson's disease, sometimes referred to as shaking palsy. Some patients require the combination of medicine, while others benefit from levodopa alone. By improving muscle control, this medicine allows more normal movements of the body.
Levodopa alone or in combination is available only with your doctor's prescription. It is available in the following dosage forms:
-
Carbidopa and Levodopa
- Tablets (U.S. and Canada)
- Extended-release tablets (U.S. and Canada)
-
Levodopa
- Tablets (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Atamet 1
- Larodopa 2
- Sinemet 1
- Sinemet CR 1
In Canada -
- Apo-Levocarb 1
- Nu-Levocarb 1
- Sinemet 1
- Sinemet CR 1
|
Note: |
For quick reference, the following medicines are numbered to match the corresponding brand names. |
| This information applies to the following medicines: | ||
| 1. | Carbidopa and Levodopa (kar-bi-DOE-pa and lee-voe-DOE-pa)‡§ | |
| 2. | Levodopa (LEE-voe-doe-pa) | |
| ‡ Generic name product may be available in the U.S. | ||
| § Generic name product may be available in Canada | ||